190 related articles for article (PubMed ID: 22773610)
21. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death.
La Gerche A; Baggish AL; Knuuti J; Prior DL; Sharma S; Heidbuchel H; Thompson PD
JACC Cardiovasc Imaging; 2013 Sep; 6(9):993-1007. PubMed ID: 24029371
[TBL] [Abstract][Full Text] [Related]
22. Discrimination of the "Athlete's Heart" from real disease by electrocardiogram and echocardiogram.
Erickson CC
Cardiol Young; 2017 Jan; 27(S1):S80-S88. PubMed ID: 28084953
[TBL] [Abstract][Full Text] [Related]
23. Beware of regression of electrocardiographic abnormalities on detraining - It may not always mean 'athlete's heart'.
Marques JP; Freitas A; Abecasis J
Rev Port Cardiol (Engl Ed); 2021 Oct; 40(10):801.e1-801.e6. PubMed ID: 34857120
[TBL] [Abstract][Full Text] [Related]
24. Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening.
Maron BJ
Br J Sports Med; 2009 Sep; 43(9):649-56. PubMed ID: 19734498
[TBL] [Abstract][Full Text] [Related]
25. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas.
Chandra N; Bastiaenen R; Papadakis M; Sharma S
J Am Coll Cardiol; 2013 Mar; 61(10):1027-40. PubMed ID: 23473408
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
[TBL] [Abstract][Full Text] [Related]
27. Left Ventricular Hypertrophy in Athletes: Differentiating Physiology From Pathology.
Augustine DX; Howard L
Curr Treat Options Cardiovasc Med; 2018 Oct; 20(12):96. PubMed ID: 30367318
[TBL] [Abstract][Full Text] [Related]
28. Re: Athlete's heart or hypertrophic cardiomyopathy?
Kuhn H
Clin Res Cardiol; 2009 Jul; 98(7):463-4; author reply 467-8. PubMed ID: 19506811
[No Abstract] [Full Text] [Related]
29. Differentiating the athlete's heart from hypertrophic cardiomyopathy.
Wasfy MM; Weiner RB
Curr Opin Cardiol; 2015 Sep; 30(5):500-5. PubMed ID: 26196658
[TBL] [Abstract][Full Text] [Related]
30. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.
Kebed KY; Bos JM; Anavekar NS; Mulvagh SL; Ackerman MJ; Ommen SR
Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003312. PubMed ID: 26162782
[No Abstract] [Full Text] [Related]
31. Sudden cardiac death and the 'athlete's heart'.
Wight JN; Salem D
Arch Intern Med; 1995 Jul; 155(14):1473-80. PubMed ID: 7605148
[TBL] [Abstract][Full Text] [Related]
32. Pathological and physiological left ventricular hypertrophy: echocardiography for differentiation.
Chelliah RK; Senior R
Future Cardiol; 2009 Sep; 5(5):495-502. PubMed ID: 19715413
[TBL] [Abstract][Full Text] [Related]
33. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes.
Pelliccia A; Di Paolo FM; Corrado D; Buccolieri C; Quattrini FM; Pisicchio C; Spataro A; Biffi A; Granata M; Maron BJ
Eur Heart J; 2006 Sep; 27(18):2196-200. PubMed ID: 16831826
[TBL] [Abstract][Full Text] [Related]
34. Unravelling the grey zone: cardiac MRI volume to wall mass ratio to differentiate hypertrophic cardiomyopathy and the athlete's heart.
Luijkx T; Cramer MJ; Buckens CF; Zaidi A; Rienks R; Mosterd A; Prakken NH; Dijkman B; Mali WP; Velthuis BK
Br J Sports Med; 2015 Nov; 49(21):1404-9. PubMed ID: 23770661
[TBL] [Abstract][Full Text] [Related]
35. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification.
Maron BJ
Cardiol Clin; 2007 Aug; 25(3):399-414, vi. PubMed ID: 17961794
[TBL] [Abstract][Full Text] [Related]
36. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy.
Maron BJ; Carney KP; Lever HM; Lewis JF; Barac I; Casey SA; Sherrid MV
J Am Coll Cardiol; 2003 Mar; 41(6):974-80. PubMed ID: 12651044
[TBL] [Abstract][Full Text] [Related]
37. [Physiological versus pathological left ventricular remodeling in athletes].
Quattrini FM; Pelliccia A
G Ital Cardiol (Rome); 2012 Apr; 13(4):273-80. PubMed ID: 22495644
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of the ECG for differential diagnosis between hypertrophic cardiomyopathy and athlete's heart: comparison between the European Society of Cardiology (2010) and International (2017) criteria.
Zorzi A; Calore C; Vio R; Pelliccia A; Corrado D
Br J Sports Med; 2018 May; 52(10):667-673. PubMed ID: 28701362
[TBL] [Abstract][Full Text] [Related]
39. Cardiac hypertrophy and how it may break an athlete's heart--the Cypriot case.
Chee CE; Anastassiades CP; Antonopoulos AG; Petsas AA; Anastassiades LC
Eur J Echocardiogr; 2005 Aug; 6(4):301-7. PubMed ID: 15992717
[TBL] [Abstract][Full Text] [Related]
40. Role of Doppler Diastolic Parameters in Differentiating Physiological Left Ventricular Hypertrophy from Hypertrophic Cardiomyopathy.
Finocchiaro G; Dhutia H; D'Silva A; Malhotra A; Sheikh N; Narain R; Ensam B; Papatheodorou S; Tome M; Sharma R; Papadakis M; Sharma S
J Am Soc Echocardiogr; 2018 May; 31(5):606-613.e1. PubMed ID: 29482976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
